Calcium gluconate

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
Calcium gluconate
Accession Number
DB11126
Type
Small Molecule
Groups
Approved, Vet approved
Description

Calcium gluconate is used as mineral supplement and medication when there is insufficient calcium in the diet. Supplementation may be done to treat or prevent osteoporosis or rickets, consequences of hypocalcemia. It can also be taken by mouth but is not recommended by injection into a muscle. Calcium Gluconate Injection, USP is a sterile, nonpyrogenic supersaturated solution of calcium gluconate for intravenous use only. Each mL contains: Calcium gluconate 94 mg; calcium saccharate (tetrahydrate) 4.5 mg; water for injection q.s. Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment (6.0 to 8.2). Calcium saccharate provides 6% of the total calcium and stabilizes the supersaturated solution of calcium gluconate. Each 10 mL of the injection provides 93 mg elemental calcium (Ca++) equivalent to 1 g of calcium gluconate.

Structure
Thumb
Synonyms
  • Calcarea gluconica
  • Calcii gluconas
  • Calcio gluconato
  • Calcium di-gluconate
  • Calcium gluconate anhydrous
  • Calcium gluconate, anhydrous
  • D-gluconic acid, calcium salt (2:1)
External IDs
E-578 / INS NO.578 / INS-578
Product Ingredients
IngredientUNIICASInChI Key
Calcium gluconate monohydrateCZN0MI5R3166905-23-5XLNFVCRGJZBQGX-XRDLMGPZSA-L
Active Moieties
NameKindUNIICASInChI Key
CalciumunknownSY7Q814VUP7440-70-2OYPRJOBELJOOCE-UHFFFAOYSA-N
Calcium cationionic2M83C4R6ZB14127-61-8BHPQYMZQTOCNFJ-UHFFFAOYSA-N
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Calcium GluconateInjection, solution94 mg/1mLIntravenousA-S Medication Solutions2000-08-09Not applicableUs
Calcium GluconateInjection, solution94 mg/1mLIntravenousFresenius Kabi2000-07-12Not applicableUs
Calcium GluconateInjection, solution98 mg/1mLIntravenousA-S Medication Solutions2017-06-15Not applicableUs
Calcium GluconateInjection, solution94 mg/1mLIntravenousRemedy Repack2015-03-162017-03-17Us
Calcium GluconateInjection, solution98 mg/1mLIntravenousAmerican Regent1992-12-01Not applicableUs
Calcium GluconateInjection, solution98 mg/1mLIntravenousHF Acquisition Co LLC, DBA HealthFirst2018-12-21Not applicableUs
Calcium GluconateInjection, solution98 mg/1mLIntravenousFresenius Kabi USA, LLC2017-06-15Not applicableUs
Calcium GluconateInjection, solution0.465 meq/1mLIntravenousGeneral Injectables & Vaccines2010-04-012013-12-01Us
Calcium GluconateInjection, solution98 mg/1mLIntravenousGeneral Injectables and Vaccines, Inc.2018-02-12Not applicableUs
Calcium GluconateInjection, solution98 mg/1mLIntravenousAmerican Regent1990-09-30Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Calcium Gluconate Tab 600mgTabletOralSwiss Herbal Remedies Ltd.1983-12-312003-09-10Canada
Calcium Gluconate Tab 648mgTabletOralPharmetics (2011) Inc.1973-12-312000-08-21Canada
Calcium Gluconate Tab 648mgTabletOralHall Laboratories, Ltd.1981-12-312003-09-11Canada
Calcium Gluconate Tab 648mg USPTabletOralLab Gernetic Int Ltee1985-12-311997-02-21Canada
Calcium Gluconate Tab 650mgTabletOralD.C. Labs Limited1969-12-312005-07-19Canada
Calcium Gluconate Tab 650mgTabletOralShoppers Drug Mart Inc.1978-12-311997-08-15Canada
Calcium Gluconate Tab 650mgTabletOralVita Health Products Inc1972-12-312002-07-31Canada
Calcium Gluconate Tab 650mgTabletOralWampole Brands, A Division Of Pangeo Pharma (Canada) Inc.1979-12-311996-09-09Canada
Calcium Gluconate Tablets 648mg USPTabletOralVita Health Products Inc1988-12-312002-07-31Canada
Calgonate Calcium Gluconate Gel 2.5%Gel2.5 g/100gTopicalDenison Pharmaceuticals, Llc2019-03-26Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Calcium LiquidCalcium gluconate (112 mg) + Calcium glucoheptonate (132 mg)LiquidOralShoppers Drug Mart Inc.1981-12-311997-08-15Canada
Calcium LiquidCalcium gluconate (112 mg) + Calcium glucoheptonate (132 mg)LiquidOralVita Health Products Inc1980-12-312002-07-31Canada
Calcium LiquidCalcium gluconate (112 mg) + Calcium glucoheptonate (132 mg)LiquidOralKsl Pharmaceuticals1994-12-311996-09-09Canada
Calcium Magnesium Plus Vitamin D LiquidCalcium gluconate (6 mg) + Ergocalciferol (2 unit) + Inositol (.6 mg) + Magnesium citrate (3 mg)LiquidOralJamp Pharma Corporation2002-04-222003-02-05Canada
Dicalcine Tab No460Calcium gluconate (155 mg) + Calcium lactate (155 mg)TabletOralHerbes Universelles Inc.1976-12-312009-07-15Canada
Liquid CalciumCalcium gluconate (112 mg) + Calcium glucoheptonate (132 mg)LiquidOralWampole Brands, A Division Of Pangeo Pharma (Canada) Inc.1998-08-122000-07-06Canada
Multiple Electrolyte Additive InjCalcium gluconate (20.6 mg) + Magnesium sulfate (19.8 mg) + Potassium chloride (29.8 mg) + Sodium chloride (46.6 mg)LiquidIntravenousInternational Medication Systems, Limited1980-12-311997-08-15Canada
Proception Sperm Nutrient DoucheCalcium gluconate (2.55 %) + Dextrose, unspecified form (71 %) + Potassium chloride (.7 %) + Sodium chloride (25.75 %)DoucheVaginalMilex Products Ltd.1951-12-311997-07-16Canada
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Calcium GluconateCalcium gluconate (94 mg/1mL)Injection, solutionIntravenousGeneral Injectables & Vaccines2015-06-112017-07-31Us
Calcium GluconateCalcium gluconate (94 mg/1mL)Injection, solutionIntravenousCardinal Health2000-08-092016-01-31Us
Calcium GluconateCalcium gluconate (94 mg/1mL)Injection, solutionIntravenousA-S Medication Solutions2000-08-09Not applicableUs
Calcium GluconateCalcium gluconate (94 mg/1mL)Injection, solutionIntravenousFresenius Kabi2000-07-12Not applicableUs
Calcium GluconateCalcium gluconate (94 mg/1mL)Injection, solutionIntravenousRemedy Repack2015-03-162017-03-17Us
Calcium GluconateCalcium gluconate monohydrate (98 mg/1mL)Injection, solutionIntravenousAmerican Regent1992-12-01Not applicableUs
Calcium GluconateCalcium gluconate (0.465 meq/1mL)Injection, solutionIntravenousGeneral Injectables & Vaccines2010-04-012013-12-01Us
Calcium GluconateCalcium gluconate monohydrate (98 mg/1mL)Injection, solutionIntravenousAmerican Regent1990-09-30Not applicableUs
Calcium GluconateCalcium gluconate (94 mg/1mL)Injection, solutionIntravenousRemedy Repack2015-10-082016-10-08Us
Calcium GluconateCalcium gluconate (94 mg/1mL)Injection, solutionIntravenousRemedy Repack2015-06-192017-07-25Us
Categories
UNII
SQE6VB453K
CAS number
299-28-5
Weight
Average: 430.372
Monoisotopic: 430.0635463
Chemical Formula
C12H22CaO14
InChI Key
NEEHYRZPVYRGPP-IYEMJOQQSA-L
InChI
InChI=1S/2C6H12O7.Ca/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1
IUPAC Name
calcium bis((2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate)
SMILES
[Ca++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O

Pharmacology

Indication

Oral calcium salts are used as dietary supplemental therapy for person who may not get enough calcium in their regular diet. Calcium gluconate is used as a cardioprotective agent in high blood potassium. Calcium gluconate is the antidote for magnesium sulfate toxicity.

Associated Conditions
Pharmacodynamics

Calcium Gluconate is the gluconate salt of calcium. An element or mineral necessary for normal nerve, muscle, and cardiac function, calcium as the gluconate salt helps to maintain calcium balance and prevent bone loss when taken orally. This agent may also be chemopreventive for colon and other cancers.

Mechanism of action

Calcium is essential for the functional integrity of the nervous, muscular, and skeletal systems. It plays a role in normal cardiac function, renal function, respiration, blood coagulation, and cell membrane and capillary permeability. Also, calcium helps to regulate the release and storage of neurotransmitters and hormones, the uptake and binding of amino acids, absorption of vitamin B 12, and gastrin secretion. The major fraction (99%) of calcium is in the skeletal structure primarily as hydroxyapatite, Ca 10(PO 4) 6(OH) 2; small amounts of calcium carbonate and amorphous calcium phosphates are also present. The calcium of bone is in a constant exchange with the calcium of plasma. Since the metabolic functions of calcium are essential for life, when there is a disturbance in the calcium balance because of dietary deficiency or other causes, the stores of calcium in bone may be depleted to fill the body's more acute needs. Therefore, on a chronic basis, normal mineralization of bone depends on adequate amounts of total body calcium.

Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption

Approximately one-fifth to one-third of orally administered calcium is absorbed in the small intestine, depending on presence of vitamin D metabolites, pH in lumen, and on dietary factors, such as calcium binding to fiber or phytates. Calcium absorption is increased when a calcium deficiency is present or when a patient is on a low-calcium diet. In patients with achlorhydria or hypochlorhydria, calcium absorption, especially with the carbonate salt, may be reduced.

Volume of distribution

Not available

Protein binding

Moderate, approximately 45% in plasma.

Metabolism

Calcium gluconate does not require hepatic metabolism for the release of Ca++ and is as effective as calcium chloride in treating ionic hypocalcemia in the absence of hepatic function.

Route of elimination

Renal (20%) - The amount excreted in the urine varies with degree of calcium absorption and whether there is excessive bone loss or failure of renal conservation. Fecal (80%) - Consists mainly of nonabsorbed calcium, with only a small amount of endogenous fecal calcium excreted.

Half life
Not Available
Clearance
Not Available
Toxicity

Infants : LDLo (Intramuscular ) : 10gm/kg ; Effects - Brain and coverings : meningeal changes Infants : TDLo ( Intramuscular ) : 143 mg/kg ; Effects - Dermatits Mouse: LD50 ( intravenous ) : 950mg/kg Mouse : LDLo (Oral ) : 10gm/kg

Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
(R)-warfarinThe therapeutic efficacy of Calcium gluconate can be decreased when used in combination with (R)-warfarin.
(S)-WarfarinThe therapeutic efficacy of Calcium gluconate can be decreased when used in combination with (S)-Warfarin.
1alpha-Hydroxyvitamin D5The risk or severity of adverse effects can be increased when Calcium gluconate is combined with 1alpha-Hydroxyvitamin D5.
1alpha,24S-Dihydroxyvitamin D2The risk or severity of adverse effects can be increased when Calcium gluconate is combined with 1alpha,24S-Dihydroxyvitamin D2.
3-Aza-2,3-Dihydrogeranyl DiphosphateCalcium gluconate can cause a decrease in the absorption of 3-Aza-2,3-Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-hydroxycoumarinThe therapeutic efficacy of Calcium gluconate can be decreased when used in combination with 4-hydroxycoumarin.
AbciximabThe therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Abciximab.
AcebutololThe therapeutic efficacy of Acebutolol can be decreased when used in combination with Calcium gluconate.
AcenocoumarolThe therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Acenocoumarol.
AcetyldigitoxinCalcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
  1. Martin TJ, Kang Y, Robertson KM, Virji MA, Marquez JM: Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function. Anesthesiology. 1990 Jul;73(1):62-5. [PubMed:2360741]
  2. Wikipedia [Link]
  3. DRUGS.COM [Link]
  4. Pubchem [Link]
  5. ChemIDplus [Link]
  6. DRUGS.COM [Link]
External Links
KEGG Compound
C08133
PubChem Compound
9290
PubChem Substance
347827907
ChemSpider
8932
ChEMBL
CHEMBL2106119
Wikipedia
Calcium_gluconate
ATC Codes
A12AA03 — Calcium gluconateD11AX03 — Calcium gluconate
AHFS Codes
  • 88:29.00* — Minerals
  • 40:12.00 — Replacement Preparations

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0RecruitingPreventionOsteoporosis1
1CompletedPreventionPaclitaxel-induced Neuropathy1
2CompletedPreventionOHSS1
2CompletedPreventionPeripheral neuropathy1
2CompletedSupportive CareEarly Breast Cancer / Joint Pain / Musculoskeletal Complications / Pain / Recurrent Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer1
3Active Not RecruitingSupportive CareOsteoporosis / Prostate Cancer1
3CompletedDiagnosticBreast Cancer / Osteoporosis1
3CompletedPreventionOvarian Hyperstimulation1
3CompletedSupportive CareChemotherapeutic Agent Toxicity / Colorectal Cancers / Neurologic toxicity / Neuropathy1
3CompletedSupportive CareColorectal Cancers / Neurologic toxicity1
3TerminatedSupportive CareNeuropathy / Pain / Recurrent Breast Carcinoma / Stage IV Breast Cancer1
Not AvailableCompletedScreeningConotruncal Cardiac Defects / Heart Defects,Congenital / Parathyroid deficiency / Pulmonary Atresia / Pulmonary Valve Stenosis / Tetralogy Of Fallot1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, solutionIntravenous0.465 meq/1mL
Injection, solutionIntravenous20 mg/1mL
Injection, solutionIntravenous94 mg/1mL
Injection, solutionIntravenous98 mg/1mL
TabletOral500 mg/1
SolutionIntramuscular; Intravenous
SolutionIntravenous
TabletOral
LiquidOral
GelTopical2.5 g/100g
TabletOral
LiquidIntravenous
LiquidIntravenous
DoucheVaginal
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
US10130646No2018-11-202038-01-11Us
US10342813No2017-07-252037-07-25Us
Additional Data Available
  • Filed On
    Filed On

    The date on which a patent was filed with the relevant government.

    Learn more

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility44.2 mg/mLALOGPS
logP-2ALOGPS
logP-3.4ChemAxon
logS-0.99ALOGPS
pKa (Strongest Acidic)3.39ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area141.28 Å2ChemAxon
Rotatable Bond Count10ChemAxon
Refractivity49.11 m3·mol-1ChemAxon
Polarizability16.62 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as sugar acids and derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbohydrates and carbohydrate conjugates
Direct Parent
Sugar acids and derivatives
Alternative Parents
Medium-chain hydroxy acids and derivatives / Medium-chain fatty acids / Beta hydroxy acids and derivatives / Hydroxy fatty acids / Monosaccharides / Secondary alcohols / Carboxylic acid salts / Polyols / Carboxylic acids / Organic calcium salts
show 6 more
Substituents
Gluconic_acid / Medium-chain hydroxy acid / Medium-chain fatty acid / Beta-hydroxy acid / Hydroxy fatty acid / Hydroxy acid / Fatty acyl / Fatty acid / Monosaccharide / Carboxylic acid salt
show 14 more
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on December 03, 2015 09:51 / Updated on December 11, 2019 03:52